Norian SRS

Norian SRS

SRS injectable cement Orthopedics A skeletal repair system consisting of injectable cancellous bone and replacement material to provide structural support to fractures, ↓ risk of loss of anatomic positioning while healing. See Bone paste.
References in periodicals archive ?
Ladd and Goodman use a product called Norian SRS (Skeletal Repair System), which they say has the advantage of allowing the body to replace the cement with new bone growth over time.
Norian SRS (Skeletal Repair System) is a fracture treatment method based on a proprietary cancellous bone cement.
The notice, issued by the Medical Devices Bureau, allows the company to market Norian SRS in Canada for the repair of distal radius (wrist) fractures.
BW HealthWire)--April 14, 1997--Norian Corporation of Cupertino, has submitted a Premarket Approval Application (PMA) to the Food & Drug Administration for an orthopaedic application of its product, Norian SRS (Skeletal Repair System).
The presentations will include results of Norian's research on the use of Norian SRS in fracture fixation and augmentation of orthopaedic hardware.
a medical device company headquartered in Cupertino, announced that it has launched a multicenter clinical trial testing the use of Norian SRS (Skeletal Repair System) in the treatment of intertrochanteric hip fractures.
announced that it has received a CE mark for its proprietary biomaterial, Norian SRS (Skeletal Repair System).
manufactures Norian SRS (Skeletal Repair System), an injectable cancellous bone fixation and replacement material designed to overcome the shortcomings of currently available fracture treatment methods.
She will take on the added role of handling product registrations, license and approval for Norian's proprietary biomaterial, Norian SRS, on a worldwide basis.
of Tokyo for marketing and distribution of Norian SRS in Japan.
In his new position, Poser will supervise scientific developments in addition to managing surgical education, surgical method development and product application development for the company's proprietary biomaterial, Norian SRS.
The company will benefit enormously from his expertise as we continue to move towards worldwide commercialization of Norian SRS.